Skip to main content
. 2019 Mar 30;38(2):392–401. doi: 10.1007/s10637-019-00758-8

Fig. 1.

Fig. 1

Duration of treatment with SMK Therapy and PFS by subject. The duration of time in months that each subject received SMK Therapy is shown by the diamond. Duration of PFS for each subject receiving SMK Therapy is shown by the bar, with the color of the bar indicating tumor type. The best response (progressive disease [PD], SD, PR, and CR) following SMK Therapy is indicated for each subject is also provided